CONTRIBUTION OF ALPHA-INTERFERON (ALPHA-IFN) TO HIV-INDUCED IMMUNOSUPPRESSION

被引:0
|
作者
LACHGAR, A
BIZZINI, B
机构
关键词
HIV INFECTION; IMMUNOSUPPRESSION; ALPHA INTERFERON; INACTIVATION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present investigation we have shown that PBLs taken from HIV-positive patients suppressed T-cell proliferation when cultured for at least 12 days. When infected In vitro with HIV-1, these cells become suppressive after 6 days. PBLs collected from seronegative individuals turned out to be non-suppressive even after prolonged culturing. However, when infected in vitro with HIV they were found to be cytostatic also after 6 days. This anti-immune activity, related to HIV infection, is mediated, at least in part, by alpha IFN, since about 50% of this HIV associated activity could be quenched by alpha IFN antibodies. We also showed that this T-cell cytostasis is associated with CD8(+) cells. In view of a possible use of suppressive cells for T-cell vaccination, we verified that such cellular functions were abolished by aldehyde treatment.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 50 条
  • [1] TREATMENT OF HAIRY-CELL LEUKEMIA WITH ALPHA-INTERFERON (ALPHA-IFN)
    LAURIA, F
    FOA, R
    RASPADORI, D
    ZINZANI, PL
    BUZZI, M
    FIERRO, MT
    BONFERRONI, M
    FANIN, R
    GALLIZIA, C
    MICHIELI, MG
    DEGANI, G
    RESEGOTTI, L
    TURA, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02): : 195 - 200
  • [2] INVESTIGATIONS CONCERNING THE MECHANISM OF ACTION OF ALPHA-INTERFERON (ALPHA-IFN) IN HAIRY-CELL LEUKEMIA (HCL) - ALPHA-IFN RECEPTORS ON HAIRY-CELLS (HCS)
    DADMARZ, R
    EVANS, T
    SECHER, DS
    MARSHALL, NJ
    CAWLEY, JC
    BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (04) : 817 - 817
  • [3] ARE TNF AND IL-2 SERUM LEVELS USEFUL MARKERS FOR THE TREATMENT WITH ALPHA-INTERFERON (ALPHA-IFN)
    BORTOLAMI, M
    FABRIS, P
    DELAZZARI, F
    FLOREANI, A
    VENTURI, C
    CHIARAMONTE, M
    NACCARATO, R
    HEPATOLOGY, 1992, 16 (02) : 517 - 517
  • [4] LOCALIZATION OF ALPHA-INTERFERON (ALPHA-IFN) BINDING TO NUCLEI ISOLATED FROM HUMAN-LYMPHOBLASTOID CELLS
    EVANS, SS
    COLLINS, TJ
    FASEB JOURNAL, 1988, 2 (06): : A1649 - A1649
  • [5] A PHASE-II TRIAL ON ALPHA-INTERFERON (ALPHA-IFN) EFFECT IN PATIENTS WITH MONOCLONAL IGM GAMMOPATHY
    ROTOLI, B
    DERENZO, A
    FRIGERI, F
    BUFFARDI, S
    MARCENO, R
    CAVALLARO, AM
    RUGGERI, P
    LISO, V
    MUSTO, P
    ANDRIANI, A
    CALLEA, V
    PIZZUTI, M
    IANNITTO, E
    CIMINO, R
    MOLICA, S
    CITARRELLA, P
    MUSOLINO, C
    GUARINO, S
    LUCARELLI, G
    ESPINOSA, A
    DELVECCHIO, L
    LEUKEMIA & LYMPHOMA, 1994, 13 (5-6) : 463 - 469
  • [6] IMMUNOTHERAPY IN RECURRENT LANGERHANS CELL HISTIOCYTOSIS (LCH) - EXPERIENCE WITH ALPHA-INTERFERON (ALPHA-IFN) AND REVIEW OF LITERATURE
    COLELLA, R
    DETERLIZZI, M
    LOIACONO, G
    SURICO, G
    MANCINI, A
    COMELLI, A
    FIORILLO, A
    DICATALDO, A
    NARDI, M
    CECI, A
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1992, 18 (06): : 619 - 625
  • [7] NON-VIROLOGICAL FACTORS RELATED TO ALPHA-INTERFERON (ALPHA-IFN) FAILURE IN THE TREATMENT OF CHRONIC HCV HEPATITIS
    FORLEO, MA
    CONTESSI, GB
    SPINETTI, A
    ZALTRON, S
    BOZZETTI, F
    HELHAMAD, I
    CASTELNUOVO, F
    BIASI, L
    ROSSINI, A
    PUOTI, M
    GASTROENTEROLOGY, 1995, 108 (04) : A1158 - A1158
  • [8] FREQUENCY OF THYROID-DYSFUNCTION AFTER ALPHA-INTERFERON (ALPHA-IFN) THERAPY IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS (CAH)
    TSIANOS, EV
    MERKOUROPOULOS, MC
    SEFERIADIS, KI
    TSATSOULIS, AA
    HEPATOLOGY, 1993, 18 (04) : A260 - A260
  • [9] HEPATIC HCV-RNA DOES PREDICT LONG-TERM RESPONSE TO ALPHA-INTERFERON (ALPHA-IFN) THERAPY
    RABINOVITZ, M
    BLOCK, G
    HEPATOLOGY, 1995, 22 (04) : 288 - 288
  • [10] RELATIONSHIP OF SERUM TRIGLYCERIDE (TG) LEVELS AND RESPONSE TO ALPHA-INTERFERON (ALPHA-IFN) IN PATIENTS WITH CHRONIC HEPATITIS-C (CHC)
    LEBOVICS, E
    ANTONECCHIA, P
    CLARK, S
    CASELLAS, A
    DWORKIN, B
    ROSENTHAL, WS
    GASTROENTEROLOGY, 1993, 104 (04) : A935 - A935